Alyeska Investment Group’s Protara Therapeutics TARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-109,405
Closed -$1.72M 821
2021
Q1
$1.72M Buy
109,405
+35,000
+47% +$551K 0.02% 485
2020
Q4
$1.8M Sell
74,405
-125,595
-63% -$3.04M 0.03% 375
2020
Q3
$3.37M Buy
+200,000
New +$3.37M 0.05% 297
2015
Q1
Sell
-1,157
Closed -$481K 545
2014
Q4
$481K Buy
+1,157
New +$481K 0.01% 422